London
· Delayed Price · Currency is GBP · Price in USD Arrowhead Pharmaceuticals Statistics
Total Valuation
LON:0HI3 has a market cap or net worth of GBP 1.99 billion. The enterprise value is 2.24 billion.
| Market Cap | 1.99B |
| Enterprise Value | 2.24B |
Important Dates
The last earnings date was Friday, January 31, 2025.
| Earnings Date | Jan 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +15.92% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 109.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 55.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.39 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.91 |
Financial Position
The company has a current ratio of 6.09, with a Debt / Equity ratio of 15.55.
| Current Ratio | 6.09 |
| Quick Ratio | 5.90 |
| Debt / Equity | 15.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.53 |
| Interest Coverage | -12.87 |
Financial Efficiency
Return on equity (ROE) is -565.33% and return on invested capital (ROIC) is -52.37%.
| Return on Equity (ROE) | -565.33% |
| Return on Assets (ROA) | -47.71% |
| Return on Invested Capital (ROIC) | -52.37% |
| Return on Capital Employed (ROCE) | -68.04% |
| Revenue Per Employee | 3,279 |
| Profits Per Employee | -839,055 |
| Employee Count | 609 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.99% in the last 52 weeks. The beta is 0.96, so LON:0HI3's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -28.99% |
| 50-Day Moving Average | 20.06 |
| 200-Day Moving Average | 22.45 |
| Relative Strength Index (RSI) | 51.02 |
| Average Volume (20 Days) | 902 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.80 |
Income Statement
In the last 12 months, LON:0HI3 had revenue of GBP 2.00 million and -510.98 million in losses. Loss per share was -4.12.
| Revenue | 2.00M |
| Gross Profit | 2.00M |
| Operating Income | -499.99M |
| Pretax Income | -518.31M |
| Net Income | -510.98M |
| EBITDA | -484.36M |
| EBIT | -499.99M |
| Loss Per Share | -4.12 |
Balance Sheet
The company has 439.99 million in cash and 696.56 million in debt, giving a net cash position of -256.57 million.
| Cash & Cash Equivalents | 439.99M |
| Total Debt | 696.56M |
| Net Cash | -256.57M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 44.79M |
| Book Value Per Share | 0.33 |
| Working Capital | 380.84M |
Cash Flow
In the last 12 months, operating cash flow was -392.42 million and capital expenditures -64.16 million, giving a free cash flow of -456.59 million.
| Operating Cash Flow | -392.42M |
| Capital Expenditures | -64.16M |
| Free Cash Flow | -456.59M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -25,037.88% |
| Pretax Margin | -25,955.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LON:0HI3 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.92% |
| Shareholder Yield | -15.92% |
| Earnings Yield | -25.74% |
| FCF Yield | -23.00% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0HI3 has an Altman Z-Score of -1.99. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.99 |
| Piotroski F-Score | n/a |